Hester Biosciences Ltd completes sale of equity investment in Texas Lifesciences Private Limited
Hester Biosciences Ltd has completed the divestment of its entire equity stake in Texas Lifesciences Private Limited (TLPL), concluding the sale transaction on 8 July 2026. The company transferred its remaining shares to existing stakeholders of TLPL for an aggregate consideration of INR 23 million.The transaction involved the transfer of 543,248 equity shares representing an initial holding of 11% in TLPL’s paid-up equity share capital. This move reduces Hester Biosciences Ltd's investment in Texas Lifesciences Private Limited to Nil.
The sale was executed in accordance with terms previously approved by the Board of Directors of Hester Biosciences Ltd.
The key details of the divestiture are summarized below:
| Metric | Details |
|---|---|
| Target Company | Texas Lifesciences Private Limited (TLPL) |
| Date of Transaction | 8 July 2026 |
| Shares Transferred | 543,248 |
| Initial Holding Percentage | 11% |
| Aggregate Consideration | INR 23 million |
| Final Shareholding Status | Nil |
Following the completion of this transfer, Hester Biosciences Ltd confirmed that it no longer holds any equity investment in TLPL.
HESTERBIO Stock Price Movement
Today, Hester Biosciences Limited shares edged higher after the markets closed, settling at ₹2102.20, up 0.11%. The equity saw a trading volume of 2,790 shares throughout the day.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.